event tracking

Epigenetics

140 results.

May 4, 2026 How Dr. Peter A. Jones transformed VAI into a research powerhouse

Dr. Peter Jones arrived in Grand Rapids with a vision: build Van Andel Institute into one of the world’s premier research organizations.

More…

April 15, 2026 CRISPR variant selectively targets tumor DNA

GRAND RAPIDS, Mich. (April 15, 2026) — Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a…

February 12, 2026 Can epigenetics help us understand Crohn’s disease?

For the millions of people worldwide with Crohn’s disease, the simple act of eating a meal can be a stressful experience.  

Crohn’s is a…

February 4, 2026 Cancer research in 2026: What’s new? What’s next?

Cancer research saves lives.

For the first time, the five-year survival rate for all cancers combined has hit 70% among people diagnosed from 2015–2021 in…

February 2, 2026 Hello from the CSO: A message from Dr. Jonathan D. Licht

Today, I enthusiastically begin my work as president and chief scientific officer of Van Andel Institute.

I’ve long admired VAI’s commitment to discovery, collaboration…

December 19, 2025 Reflecting on research: 2025 highlights

In 2025, VAI continued to build scientific momentum and drive discoveries that deepen our understanding of human health. With the addition of new faculty and…

November 4, 2025 Fighting to outsmart cancer: A Q&A with graduate student Yanqing Liu

Cancers are notorious for finding ways to resist treatment.

Van Andel Institute’s Yanqing Liu, a Ph.D. student in the lab of Scott Rothbart,…

October 29, 2025 Eminent physician-scientist Dr. Jonathan D. Licht to serve as next president and chief scientific officer of Van Andel Institute

Grand Rapids, Mich. (Oct. 29, 2025) — Van Andel Institute, a leading research organization based in Grand Rapids, Michigan, has appointed internationally recognized physician-scientist…